CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy

被引:1
|
作者
Hoshimoto, K [1 ]
Hayashi, M [1 ]
Ohkura, T [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Obstet & Gynecol, Koshigaya Hosp, Koshigaya, Saitama 343, Japan
关键词
CD26; expression; CD30; lymphocyte; pregnancy; cytokine balance;
D O I
10.1159/000052932
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
It is increasingly apparent that the Th1/Th2 cell ratio is decreased during pregnancy. In a previous study, we revealed that combined analysis of soluble CD26 and CD30 might be a potent surrogate tool for evaluating the Th1/Th2 balance during pregnancy. Therefore, in the present study, we elucidated whether the CD26 and CD30 expression on the surface of lymphocyte is useful marker for Th1 and Th2 lymphocytes, respectively, during pregnancy with flow cytometric technique. The peripheral blood samples were obtained from 6 non-pregnant healthy women, 8 healthy pregnant women in the first trimester and 12 pregnant women in the third trimester. The mean percentages of CD26 expression did not differ significantly among these groups (p = 0.45). Also, the mean percentages of CD30 expression did not differ significantly among these groups (p = 0.32). From the present study, the expression of CD26 and CD30 did not appear to be a useful marker for Th1 and Th2 lymphocytes during pregnancy. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 50 条
  • [21] Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30- Tumors
    Hombach, Andreas A.
    Rappl, Gunter
    Abken, Hinrich
    MOLECULAR THERAPY, 2019, 27 (10) : 1825 - 1835
  • [22] The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice
    Fuchiwaki, Takafumi
    Sun, Xun
    Fujimura, Kenjiro
    Yamada, Hisakata
    Shibata, Kensuke
    Muta, Hiromi
    Podack, Eckhard R.
    Kawauchi, Hideyuki
    Yoshikai, Yasunobu
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (10) : 2947 - 2954
  • [23] CD26 a cancer stem cell marker and therapeutic target
    Davies, Samuel
    Beckenkamp, Aline
    Buffon, Andreia
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 71 : 135 - 138
  • [24] CD26: A negative selection marker for human Treg cells
    Salgado, Francisco J.
    Perez-Diaz, Amparo
    Villanueva, Nora M.
    Lamas, Olaya
    Arias, Pilar
    Nogueira, Montserrat
    CYTOMETRY PART A, 2012, 81A (10) : 843 - 855
  • [25] Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
    Fujimoto, Nobukazu
    Ohnuma, Kei
    Aoe, Keisuke
    Hosono, Osamu
    Yamada, Taketo
    Kishimoto, Takumi
    Morimoto, Chikao
    PLOS ONE, 2014, 9 (12):
  • [26] Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors
    Eric-Nikolic, Aleksandra
    Matic, Ivana Z.
    Dordevic, Milica
    Milovanovic, Zorka
    Markovic, Ivan
    Dzodic, Radan
    Inic, Momcilo
    Srdic-Rajic, Tatjana
    Jevric, Marko
    Gavrilovic, Dusica
    Cordero, Oscar. J.
    Juranic, Zorica D.
    IMMUNOBIOLOGY, 2011, 216 (08) : 942 - 946
  • [27] CD30 and PD-1 in mycosis fungoides
    Inan, Mehmet
    Ogut, Betul
    Gurer, Mehmet
    Erdem, Ozlem
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2023, 17 (03): : 93 - 99
  • [28] Suppression of CD26 inhibits growth and metastasis of pancreatic cancer
    Ye, Chunxiang
    Tian, Xiuyun
    Yue, Guanjun
    Yan, Liang
    Guan, Xiaoya
    Wang, Shan
    Hao, Chunyi
    TUMOR BIOLOGY, 2016, 37 (12) : 15677 - 15686
  • [29] Diagnostic, prognostic and therapeutic role of CD30 in lymphoma
    Pierce, John Matthew R.
    Mehta, Amitkumar
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (01) : 29 - 37
  • [30] CD30 Is a Potential Therapeutic Target in Malignant Mesothelioma
    Dabir, Snehal
    Kresak, Adam
    Yang, Michael
    Fu, Pingfu
    Wildey, Gary
    Dowlati, Afshin
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (03) : 740 - 746